O

Oyster Point Pharma

75 employees

Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases. Show more Show less

Investor insights

Funding rounds participated in

$121M sweet spot round size

Investor type

Public Company

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Date founded

2015

Funding rounds raised

Total raised

$121M

from investors over 1 rounds

O

Oyster Point Pharma raised $121M on June 12, 2020